FACTANKER · measured, cited, anchored official records connected
FACTANKERSearch ↗

ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period

HEMOGENYX PHARMACEUTICALS PLC: ifrs:CashFlowsFromUsedInFinancingActivities

One fact, its scope and the complete path back to the official record.

Period: 2024-01-01 – 2024-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/2c35ed47-abf5-4d3d-9562-d9f459a25f60

Reported value

3.077M{"amount": 3077453.0}
Entity
HEMOGENYX PHARMACEUTICALS PLC
Metric
ifrs:CashFlowsFromUsedInFinancingActivities
Period
2024-01-01 – 2024-12-31
Status
current
Source
ESEF — Europäische Jahresabschlüsse (iXBRL)

Provenance

Official referenceesef:2138008L93GYU5GN6179:2024-12-31
Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T23:04:53.355718+02:00
Raw response SHA-2560c5d6c4a8d9962ade23d91dee1fbeea6…
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.

All facts for this organization →Query facts through API / MCP →Versioning policy →
From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies